- Home
- ONB vs ROIV Comparison
ONB vs ROIV Comparison
Compare ONB & ROIV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONB
- ROIV
- Stock Information
- Founded
- ONB 1834
- ROIV 2014
- Country
- ONB United States
- ROIV United Kingdom
- Employees
- ONB N/A
- ROIV N/A
- Industry
- ONB Major Banks
- ROIV Biotechnology: Pharmaceutical Preparations
- Sector
- ONB Finance
- ROIV Health Care
- Exchange
- ONB Nasdaq
- ROIV Nasdaq
- Market Cap
- ONB 7.9B
- ROIV 7.8B
- IPO Year
- ONB N/A
- ROIV N/A
- Fundamental
- Price
- ONB $20.86
- ROIV $10.99
- Analyst Decision
- ONB Buy
- ROIV Buy
- Analyst Count
- ONB 9
- ROIV 4
- Target Price
- ONB $26.11
- ROIV $17.50
- AVG Volume (30 Days)
- ONB 3.7M
- ROIV 5.1M
- Earning Date
- ONB 07-22-2025
- ROIV 05-29-2025
- Dividend Yield
- ONB 2.69%
- ROIV N/A
- EPS Growth
- ONB N/A
- ROIV N/A
- EPS
- ONB 1.72
- ROIV N/A
- Revenue
- ONB $1,795,802,000.00
- ROIV $29,053,000.00
- Revenue This Year
- ONB $44.42
- ROIV N/A
- Revenue Next Year
- ONB $16.19
- ROIV N/A
- P/E Ratio
- ONB $12.14
- ROIV N/A
- Revenue Growth
- ONB 3.29
- ROIV N/A
- 52 Week Low
- ONB $15.60
- ROIV $8.73
- 52 Week High
- ONB $24.49
- ROIV $13.06
- Technical
- Relative Strength Index (RSI)
- ONB 46.80
- ROIV 52.59
- Support Level
- ONB $20.17
- ROIV $10.59
- Resistance Level
- ONB $21.62
- ROIV $11.37
- Average True Range (ATR)
- ONB 0.49
- ROIV 0.32
- MACD
- ONB -0.13
- ROIV -0.01
- Stochastic Oscillator
- ONB 27.27
- ROIV 52.23
About ONB Old National Bancorp
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.